A berrant humoral responses have a key role in the pathogenesis of systemic lupus erythematosus (SLE) 1 . While the expansion of germinal center (GC) B cell and plasma cell (PC) populations has long been associated with SLE, additional B cell subsets might also contribute to this disease. Studies of aging mice have identified a B cell subset, age-associated B cells (ABCs), that exhibits a unique phenotype and 'preferentially' expands in females with increasing age 2-4 . In addition to expressing classical B cell markers, ABCs also express the myeloid markers CD11c and CD11b 2-4 . The formation of ABCs is promoted by the cytokines IFN-γ and IL-21 and by engagement of the receptors TLR7 and TLR9 3,5,6 . While ABCs exhibit somatic hypermutation 7 , their relationship with GC B cells and PCs is not yet understood. ABCs increase in abundance prematurely in mouse lupus and produce antibodies directed against chromatin 2,8 . ABC-like B cells (which include IgD -CD27and CD21 lo B cells) have been detected in human autoimmune disorders, including SLE 4, 9, 10 . ABCs express T-bet and depend on this transcription factor for their generation; thus, they are also known as CD11c + T-bet + B cells 6,11 . The molecular pathways that promote the expansion and pathogenicity of the ABC population in autoimmunity remain largely unknown.
IRF5 is expressed in myeloid cells and regulates the polarization of macrophages into the classically activated, inflammatory M1 phenotype and the production of IFN-α and of proinflammatory cytokines 15, 16, 21 . Estrogen can modulate the abundance of IRF5 in B cells 22 , in which IRF5 regulates class switching to immunoglobulin G2a (IgG2a) and/or IgG2c and expression of the transcription factor Blimp1 19, 23 .
A search for proteins that interact with IRF4 led to the isolation of the protein DEF6 (also known as IBP or SLAT) [24] [25] [26] . DEF6 exhibits substantial homology to only one other protein, SWAP-70 [24] [25] [26] [27] . SWAP-70 and DEF6 constitute the SWEF family, a unique family of Rho GTPase-regulatory proteins that control both cytoskeletal dynamics and IRF4 activity [24] [25] [26] [27] [28] [29] [30] . Notably, the DEF6 locus has been identified as a genetic risk factor for human SLE 31 . The SWEF proteins have an important immunoregulatory role, and the simultaneous lack of SWAP-70 and DEF6 in C57BL/6 mice (double-knockout (DKO) mice) leads to the spontaneous development of lupus, which, like human SLE, 'preferentially' affects females 32 . Autoimmunity in DKO mice is associated with dysregulation of T cells and B cells, increased production of IL-21 and enhanced formation of GC B cells and PCs 32 .
Since ABCs accumulate in autoimmune mice, we investigated this B cell subset in DKO mice. DKO mice exhibited IL-21dependent expansion of a proliferating ABC population with proinflammatory abilities. DKO ABCs produced autoantibodies and displayed a transcriptome distinct from that of wild-type ABCs, marked by increased transcription of immunoglobulinencoding genes and diminished expression of molecules in a subset of myeloid-related programs. DKO ABCs exhibited a unique chromatin landscape that showed enrichment for open chromatin regions containing binding motifs for IRF, AP-1-BATF and T-bet. In the absence of the SWEF proteins, stimulation of B cells with IL-21 led to dysregulated IRF5 activity and the generation of ABCs. Furthermore, the population expansion of ABCs and development of lupus in female DKO mice was controlled by IRF5. Thus, IRF5 was a regulator of ABCs in these autoimmune settings.
Results

Spontaneous expansion of the ABC population in DKO mice.
The spontaneous development of autoimmunity in female DKO mice led us to investigate whether ABCs accumulated prematurely in DKO mice. The frequency and number of splenic B cells expressing CD11c and CD11b were much greater in female DKO mice than a, Flow cytometry of B220 + or B220 + CD19 + cells (above plots) from the spleen of female wild-type (WT) and DKO mice over 23 weeks of age (above plots), analyzing the expression of CD11c and CD11b (left), and frequency (middle) and number (right) of CD11c + CD11b + cells in mice as at left. Numbers adjacent to outlined areas (left) indicate percent CD11c + CD11b + cells. Data are representative of eight independent experiments (B220 + cells; n = 12 wild-type mice and n = 16 DKO mice) or three independent experiments (B220 + CD19 + cells; n = 3 wild-type mice and n = 6 DKO mice). **P = 0.0014 and ****P < 0.0001 (two-tailed Student's t-test). b, Flow cytometry of B220 + CD19 + cells from the spleen of female wild-type, DKO, Def6 -/and Swap70 -/mice 18-24 weeks of age (above plots), as in a. Data are representative of three independent experiments (n = 3 wild-type mice, n = 4 Swap70 -/mice, n = 5 Def6 -/mice and n = 5 DKO mice). NS, not significant (P ≥ 0.05); *P = 0.0403 and ****P < 0.0001 (one-way analysis of variance (ANOVA) followed by Bonferroni's multiple-comparisons test). c, Expression of various markers (below plots) on B220 + CD19 + CD11c + CD11b + or B220 + CD19 + CD11c -CD11b -B cells (key) from the spleen of female DKO mice over 18 weeks of age. Data are representative of seven independent experiments with n = 11 mice (T-bet, CD21 and CD23); four independent experiments with n = 6 mice (CD86 and major histocompatibility complex class II (MHCII)); three independent experiments with n = 5 mice (IgD, IgM, CD43 and CD93); or two independent experiments with n = 4 mice (CD5). d, ELISA of IgG antibodies to dsDNA (IgG2c), nRNP and cardiolipin in the supernatants of sorted ABCs (B220 + CD1 9 + CD11c + CD11b + ) and FoB cells (B220 + CD19 + CD11c -CD11b -CD23 + ) left unstimulated (-) or stimulated for 7 d in vitro with imiquimod (1 μ g/ml) (+ imiq) (key); results are presented as optical density at 450 nm (OD 450 in wild-type mice, regardless of the gating strategy (Fig. 1a ). The accumulation of these cells was not due to an increase in plasmacytoid dendritic cells ( Supplementary Fig. 1a ). While wild-type ABCs are normally detected in mice after 12 months of age 4 , DKO ABCs started to appear by 10 weeks of age ( Supplementary Fig. 1b ) and constituted ≈ 10% of the splenic B cells in mice over 23 weeks of age ( Fig. 1a ). Minimal expansion of the ABC population was detected in DKO lymph nodes ( Supplementary Fig. 1c ). Mice lacking either SWAP-70 or DEF6 alone did not exhibit a significantly greater abundance of ABCs relative to that in wild-type mice (Fig. 1b) . Thus, the premature population expansion of CD11c + CD11b + B cells observed in vivo in DKO mice required the simultaneous absence of both SWEF proteins. We next assessed the expression of several markers whose presence or absence defines ABCs [2] [3] [4] . The expression of T-bet was significantly higher in CD11c + CD11b + DKO B cells than in CD11c -CD11b -DKO B cells ( Fig. 1c ) and corresponded to substantial population expansion of CD11c + T-bet + B cells in DKO mice ( Supplementary Fig. 1d ). Moreover, CD11c + CD11b + DKO B cells downregulated their expression of CD21 and CD23, displayed biphasic expression of IgD, had large amounts of IgM, CD86 and major histocompatibility complex class II and did not express CD43, CD93 or CD5 ( Fig. 1c ). While most CD11c + CD11b + DKO B cells expressed IgM, a small number expressed IgG1 and IgG2c ( Supplementary Fig. 1e ). Thus, the CD11c + CD11b + DKO B cells had all the typical phenotypic features of the previously described mouse ABCs 2-4 , including high expression of T-bet; hence, they are called ' ABCs' here.
To assess the ability of ABCs to produce autoantibodies, we sorted ABCs from DKO mice ( Supplementary Fig. 1f ) and cultured them in vitro with the TLR7 agonist imiquimod. ABCs from DKO mice secreted IgG2c antibody to double-stranded DNA (anti-dsDNA), but not IgG1 anti-dsDNA, after stimulation; however, follicular B cells (FoB cells) from DKO mice did not ( Fig. 1d and data **** **** **** **** wild-type and DKO mice 8-10 weeks of age (left margin) stimulated for 3 d with anti-IgM (5 μ g/ml) and anti-CD40 (5 μ g/ml) alone (-) or together with IL-21 (50 ng/ml) or imiquimod (1 μ g/ml) (above plots), and frequency of ABCs (B220 + T-bet + CD11c + cells) (right) in cultures as at left. Numbers in quadrants (left) indicate percent cells in each. Data are representative of five independent experiments with n = 5 cultures. ****P < 0.0001 (one-way ANOVA followed by Bonferroni's multiple-comparisons test). b, Flow cytometry of B220 + cells from the spleen of female wild-type, DKO and Il21 -/-DKO mice over 24 weeks of age (above plots), analyzing the expression of CD11c and CD11b (left), and frequency (middle) and number (right) of ABCs (B220 + CD11c + CD11b + cells) in mice as at left. Numbers adjacent to outlined areas (left) indicate percent CD11c + CD11b + cells. Data are representative of four independent experiments with n = 5 wild-type mice, n = 6 DKO mice and n = 8 Il21 -/-DKO mice. ***P = 0.0002 and ****P < 0.0001 (one-way ANOVA followed by Bonferroni's multiple-comparisons test). c, Flow cytometry of B220 + cells from the spleen of female wildtype, DKO and Sap -/-DKO mice over 24 weeks of age (above plots), as in b. Data are representative of four independent experiments with n = 4 wild-type mice, n = 4 DKO mice and n = 7 Sap -/-DKO mice. ****P < 0.0001 (one-way ANOVA followed by Bonferroni's multiple-comparisons test). d, ELISA of IgG antibodies to dsDNA in the serum of wild-type, DKO, Il21 -/-DKO, and Sap -/-DKO mice (horizontal axis). Data are representative of four independent experiments with n = 6 wild-type mice, n = 8 DKO mice, n = 8 Il21 -/-DKO mice and n = 6 Sap -/-DKO mice. ****P < 0.0001 (one-way ANOVA followed by Bonferroni's multiple-comparisons test). Each symbol represents an individual culture (a) or mouse (b-d); small horizontal lines indicate the mean. not shown). Stimulated DKO ABCs also produced antibodies to nuclear ribonuclear protein (nRNP) and IgG antibodies to cardiolipin ( Fig. 1d ). ABCs might thus directly contribute to lupus in DKO mice by producing autoantibodies.
Articles
NATuRE ImmuNoLoGy
IL-21 regulates the generation of DKO ABCs in vitro and in vivo.
The generation of mouse ABCs can be promoted by IL-21 and TLRs 3,5,6 . We thus directly investigated the ability of these signals to drive ABC formation in vitro from the B cells of 8-to 10-weekold wild-type and DKO mice. The addition of IL-21 resulted in a significantly greater population of CD11c + T-bet + ABCs in cultures of DKO B cells than in those of wild-type B cells, but the addition of imiquimod did not ( Fig. 2a ). Similar results were obtained with CD11c and CD11b as markers ( Supplementary Fig. 2a ). As reported 5 , the stimulation of wild-type and DKO B cells with either IL-4 or IFN-γ alone did not generate CD11c + T-bet + B cells, and the addition of IL-4 inhibited the IL-21-mediated formation of these cells in both wild-type cultures and DKO cultures ( Supplementary  Fig. 2b ). DKO B cells therefore exhibited an increased ability to generate ABCs in vitro after stimulation with IL-21.
To further evaluate the importance of IL-21 in the expansion of the DKO ABC population, we assessed female DKO mice lacking Il21 (Il21 -/-DKO mice). The accumulation of ABCs was completely abolished in these mice, in contrast to the presence of Ighv1-61  Lamp3  Gnb4  Gm16710  Thsd7a  Havcr1  Lmo7  II9r  Ighv5-16  Ighv1-52  Ighv14-3  Ffar2  Slc30a4  Ighg1   Ighe   Igkv6-14 Zfp365
Igkv5-45 such cells in age-matched female DKO mice (Fig. 2b) . Il21 -/-DKO mice also failed to accumulate follicular helper T cells (T FH cells), GC B cells or PCs and did not produce autoantibodies to dsDNA ( Fig. 2d and Supplementary Fig. 2c-f ). In addition to being produced by T FH cells, IL-21 can also be produced by innate sources 33 .
To determine whether direct T cell-B cell contacts were necessary for the population expansion of DKO ABCs in vivo, we assessed their presence in DKO mice lacking Sh2d1a, which encodes the adaptor SAP ('signaling lymphocytic-activation moleculeassociated protein'; called 'Sap' here: Sap -/-DKO mice), which mediates sustained T cell-B cell interactions 34 . The absence of SAP in DKO mice strongly inhibited the accumulation of ABCs, T FH cells, GC B cells and PCs and autoantibody production ( Fig.  2c,d and Supplementary Fig. 2c-f ). Thus, the aberrant population expansion of DKO ABCs was dependent on IL-21 and cognate T cell-B cell interactions.
SWEF proteins regulate the proliferation and proinflammatory ability of ABCs.
To gain insight into the mechanisms by which the SWEF proteins regulate ABCs, we next sorted B cells on the basis of their expression of CD11c and CD11b and employed RNA-based next-generation sequencing (RNA-seq) to compare the transcriptomes of wild-type FoB cells, DKO FoB cells and DKO ABCs. A total of 3,049 genes were expressed differentially by the three different populations (a change in expression of onefold (log value); false-discovery rate (FDR), < 0.01) ( Fig. 3a) . A set of genes were either upregulated (cluster 2) or downregulated (cluster 1) in DKO B cells regardless of their expression of CD11c and CD11b (Fig. 3a) , which suggested that the lack of SWEF proteins altered the expression of these genes in B cells independently of their differentiation state. On the basis of gene-set-enrichment analysis (GSEA) ( Fig. 3b and Supplementary Fig. 3a ), we concluded that the lack of SWEF proteins affected the control of B cell proliferation, potentially via the E2F family of transcription factors and regulators of the G2-M checkpoint. Analysis of staining with the proliferation marker Ki67 revealed that CD11c -T-bet -DKO B cells included a smaller population of highly proliferative cells than did their wild-type counterparts ( Fig. 3c ). DKO ABCs proliferated even more robustly than did CD11c -T-bet -DKO B cells ( Fig. 3c ). No differences in apoptosis were observed ( Supplementary Fig. 3b ). In vitro experiments demonstrated that DKO ABCs proliferated to a greater extent than did wild-type ABCs after stimulation with IL-21 ( Supplementary   Fig. 3c ) while exhibiting similar survival ( Supplementary Fig. 3d,e ). Thus, SWEF proteins regulated the proliferation of B cells and had an important role in restraining ABC proliferation in response to IL-21.
In addition to the DKO cell-specific clusters 1 and 2, clusters 3 and 5 were uniquely regulated in DKO ABCs and not in FoB cells from either wild-type mice or DKO mice (Fig. 3a,d) . As expected, DKO ABCs exhibited higher expression of Tbx21 (which encodes T-bet), Itgax (which encodes the integrin subunit α X (CD11c)) and Itgam (which encodes the integrin subunit α M (CD11b)) than that of FoB cells (Fig. 3d ). GSEA indicated that among the sets showing the greatest enrichment (FDR, q < 0.05) in DKO ABCs relative to the number of genes in those sets that were expressed in FoB cells, several gene sets were related to the control of inflammation, chemotaxis, integrin binding and cell adhesion (Fig. 3d,e and Supplementary Fig. 3f ). Prominent among the upregulated genes were various genes encoding chemokines (for example, Cxcl9, Cxcl10 and Ccl5), cytokine receptors (for example, Il1r2, Il12rb2 and Il18r1) and cytokines ( Fig. 3d and Supplementary Fig. 3f ); some of these results were further validated by qPCR in sorted cells (Fig. 3f) . Thus, DKO ABCs were endowed with greater proinflammatory ability than that of FoB cells and had unique migratory and adhesive attributes relative to those of FoB cells.
The chromatin landscape of DKO ABCs shows enrichment for IRF and AP-1-BATF motifs.
We next employed an assay for transposase-accessible chromatin followed by deep sequencing (ATAC-seq) 35 to investigate the chromatin landscape of DKO ABCs. ATAC-seq signals from DKO ABCs were compared with those of DKO FoB cells sorted from the same mice (Fig. 4a ). We identified 3,666 ABC-specific peaks that were found mainly in intergenic and intronic regions and only rarely in promoters (Fig. 4b ). Loci with accessibility in ABCs different from that in FoB cells included those encoding proinflammatory cytokines (such as Ifng and Il6) and other key genes (such as the Cxcl10 cluster of genes) ( Fig. 4c ). ABCspecific peaks were associated with genes that were more transcriptionally active in DKO ABCs than in DKO FoB cells, and pathway analysis showed that many of the differentially expressed ATAC-seq associated genes encoded molecules involved in locomotion and cellular adhesion ( Supplementary Fig. 4a-c) .
To gain insight into the mechanisms underlying the distinctive chromatin profile of DKO ABCs, we identified the transcription factor-binding motifs over-represented in ABC-specific peaks (Fig. 4d ). ABC-specific accessible loci displayed enrichment for binding motifs for AP-1-BATF, IRFs and T-bet (Fig. 4d) . The ABC-specific peaks exhibited substantial positional bias in the distribution of binding motifs for IRFs and T-bet that coincided with the peak summit (Fig. 4e ). In contrast, FoB cell-specific peaks exhibited enrichment for motifs for a distinct set of transcription factors, including POU2F2 (Fig. 4d,e ). Thus, DKO ABCs exhibited a unique chromatin landscape that, in addition to showing enrichment for T-bet motifs, showed enrichment for IRF and AP-1-BATF motifs and correlated with a distinctive transcriptional profile.
Distinctive transcriptional and epigenomic programs of ABCs from autoimmunity-prone DKO mice.
We next investigated whether the transcriptional profiles of ABCs from autoimmunityprone mice differed from those of the ABCs that slowly accumulated in aging wild-type female mice. ABCs from wild-type and age-matched DKO mice had similar expression of Tbx21 ( Supplementary Fig. 5a ). A total of 711 genes were expressed differentially by the two populations (change in expression of onefold (log value); FDR < 0.01); among these, 111 genes were upregulated and 600 genes were downregulated in DKO ABCs relative to their expression in wild-type ABCs (Fig. 5a ). DKO ABCs expressed several immunoglobulin-encoding gene transcripts more abundantly than did wild-type ABCs but downregulated a subset of myeloidrelated transcripts (Fig. 5a,b and Supplementary Table 1 ). No change in the expression of genes encoding key regulators of PC differentiation, such as Irf4, Irf8, Bcl6 or Prdm1 ( Supplementary Fig. 5a ), was detected in DKO ABCs, which suggested that the differences were not due to the presence of contaminating plasmablasts. However, DKO ABCs exhibited alterations in the expression of genes encoding other transcription factors, including upregulation of Jun and Nfil3 and downregulation of Maf, Mafb and Pparg, while their Spi1 expression was similar to that of wild-type ABCs ( Fig. 5c and Supplementary Fig. 5a ). Differential expression of selected genes, including genes, encoding key regulators of the engulfment of apoptotic cells, such as Mertk and Axl, was further confirmed by qPCR ( Fig. 5c ). Thus, ABCs from autoimmunity-prone DKO mice were endowed with a greater immunoglobulin-producing capacity than that of wild-type ABCs but downregulated their expression of genes encoding some of the myeloid-related features associated with this B cell subset.
To identify the differences in the chromatin landscapes of wildtype ABCs and DKO ABCs that might accompany the distinct transcriptional profiles noted above, we compared the ATAC-seq signals of sorted ABCs from wild-type and age-matched DKO mice. We identified 27,483 wild-type ABC-specific peaks and 1,583 DKO ABC-specific peaks (Fig. 5d ). Most of the wild-type ABC-or DKO ABC-specific peaks were found mainly in intergenic and intronic regions and only rarely in promoters ( Supplementary Fig. 5b ). DKO ABC-specific accessible loci displayed enrichment for binding motifs for IRF, AP-1-BATF and T-bet (Fig. 5e ). In contrast, wild-type ABC-specific peaks were associated with enrichment for binding motifs for the transcription factors PU.1, MAF and C/EBP (Fig. 5e ). These results were consistent with the downregulation of Maf and Mafb observed in DKO ABCs and were reflected in differences in the accessibility of the Maf and Mafb loci detected by ATAC-seq (Supplementary. 5c). Gene-ontology categories of genes associated with wild-type cell-or DKO cell-specific peaks indicated that wild-type ABC-specific peaks were positively associated with the transcriptional programs of genes encoding molecules that regulate phagocytosis and other myeloid-related functions, while DKO ABC-specific peaks showed enrichment for genes encoding molecules in processes linked to B cell differentiation, B cell activation, and immunoglobulin regulation (Fig. 5f) . These findings supported the idea that the difference between wild-type ABCs and DKO ABCs in chromatin accessibility was functionally important. Thus, the chromatin landscape of ABCs from autoimmunity-prone mice was characterized by dual abnormalities, relative to that of wild-type ABCs, whereby enrichment for IRF and AP-1-BATF motifs was coupled to depletion of PU.1-and MAF-bound regulatory regions.
IRF5 regulates the IL-21-mediated formation of DKO ABCs.
The enrichment for IRF motifs in the chromatin landscape of DKO ABCs suggested that IRFs might contribute to the generation and/ or function of ABCs. Since the SWEF proteins can regulate IRF4 activity 32, 36, 37 , we first investigated whether DKO ABCs depended on IRF4. Analysis of Cd11c-Cre Irf4 fl/fl DKO mice (with deletion of loxP-flanked Irf4 alleles (Irf4 fl/fl ) by Cre recombinase expressed from the promoter of Itgax (called 'Cd11c' here: Cd11c-Cre)), previously generated to evaluate dendritic cells 37 , revealed that deletion of Irf4 in CD11c-expressing cells did not significantly affect the accumulation of ABCs ( Supplementary Fig. 6a ) or other parameters of autoimmunity 37 , which suggested that DKO ABCs might not require IRF4.
Given the homology among IRF DNA-binding domains, we next pursued the possibility that another IRF might regulate DKO ABCs. We focused on IRF5, given its ability to regulate the production of IgG2a-IgG2c and IL-6 and the strong association of IRF5 variants with SLE 15, 16 . To facilitate our studies, we generated DKO mice lacking Irf5 in B cells (Cd21-Cre Irf5 fl/-DKO mice) and assessed formation of ABCs in vitro in these mice. Irf5 expression was similar in wild-type B cells and DKO B cells and was absent from B cells from Cd21-Cre Irf5 fl/-DKO mice ( Supplementary Fig. 6b ). Lack of Irf5 substantially diminished the IL-21-driven ability of DKO B cells to generate ABCs (Fig. 6a,b) and produce IL-6, CXCL10 and IgG2c (Fig. 6c-e ) but did not affect the production of IgG1 (Fig. 6e) . Expression of Jun, a known target of IRF5 38 , was also dysregulated in DKO B cells in an IL-21-and Irf5-dependent manner (Fig. 6f) . Thus, the IL-21-driven abnormalities in the generation and function of DKO ABCs were dependent on IRF5.
Since the ATAC-seq had revealed enrichment for IRF-binding sites in ABC-specific peaks located at the Il6 transcription start site (TSS), the Cxcl10 cluster, the Ighg2c region and Jun, we next performed chromatin-immunoprecipitation (ChIP) assays to assess the binding of IRF5 to these regulatory regions. DKO B cells exhibited enhanced binding of IRF5 to these sites relative to that of wild-type B cells only after stimulation with IL-21 ( Fig. 7a and Supplementary  Fig. 7a ). IL-21-mediated phosphorylation of the transcription factor STAT3 and translocation of IRF5 to the nucleus were similar in wild-type and DKO B cells ( Supplementary Fig. 7b,c) . Minimal IRF5 binding was observed in Cd21-Cre Irf5 fl/-DKO B cells ( Fig. 7a and Supplementary Fig. 7a ), in support of the specificity of the findings. To evaluate whether ABC-specific peaks bound by IRF5 could also be targeted by T-bet, we performed ChIP assays with anti-T-bet ( Fig. 7b and Supplementary Fig. 7a ). DKO B cells exhibited increased binding of T-bet to the ABC-specific regions at the Cxcl10 cluster, the Ighg2c peak and Jun but not to the Il6 TSS or a site in Zeb2 known not to bind T-bet 39 . Notably, deletion of Irf5 in DKO B cells resulted in decreased binding of T-bet to the Cxcl10 cluster, the Ighg2c peak and Jun. Further confirmation that stimulation of DKO B cells with IL-21 led to aberrant ability of IRF5 and T-bet to target the Cxcl10 cluster was obtained by oligonucleotideprecipitation assays (ONP assays). As observed with the ChIP assays, the presence of IRF5 was necessary for T-bet to bind to the Cxcl10 cluster, while no binding of T-bet to the Il6 TSS was detected ( Fig. 7c and Supplementary Fig. 7d ). Co-transfection of cells with constructs encoding T-bet with IRF5, coupled with a mutational analysis, confirmed that optimal recruitment of T-bet to the Cxcl10 cluster required DNA binding by IRF5 ( Fig. 7d and Supplementary  Fig. 7e ). Together these findings supported a model whereby in the absence of the SWEF proteins, stimulation with IL-21 leads to increased ability of IRF5 to target ABC-specific peaks. Targeting of these regions by IRF5 subsequently enables the recruitment of T-bet to a subset of these sites.
We next investigated the possibility that the SWEF proteins were able to interact with IRF5 and thus restrain its activity. Endogenous IRF5 in B cells was found to interact with both DEF6 and SWAP-70 (Fig. 7e) . The association of IRF5 with either DEF6 or SWAP-70 mapped to the C-terminal portion of the SWEF proteins, which contains their IRF-interacting region, and required the IRF-association domain of IRF5 ( Supplementary Fig. 7f-h) . No interaction of either DEF6 or SWAP-70 with T-bet was detected ( Supplementary Fig. 7i ). Co-transfection of a construct encoding IRF5 with a construct encoding DEF6 or SWAP-70, followed by an ONP assay, demonstrated that the full-length SWEF proteins interfered with the ability of IRF5 to bind to the Il6 TSS, but mutants unable to interact with IRF5 did not (Fig. 7f ). In the course of these studies, we also observed that DEF6 and SWAP-70 were able to form heterodimers ( Supplementary Fig. 7j ). These results suggested that the interaction of IRF5 with the SWEF proteins was able to regulate IRF5's activity and thus indirectly altered the recruitment of T-bet to selected target genes.
Monoallelic deletion of Irf5 abolishes the accumulation of ABCs and lupus development in DKO mice.
We next evaluated the effect of Irf5 deficiency on the in vivo population expansion of DKO ABCs. Monoallelic deletion of Irf5 significantly decreased the accumulation of ABCs regardless of the markers used to identify these cells (Fig. 8a,b and Supplementary Fig. 8a,b ). Further deletion of Irf5 using Cd21-Cre or Cd11c-Cre to target B cells or CD11c + cells, respectively, did not exert additional effects (Fig. 8a,b and Supplementary Fig. 8a-c) . Loss of ABCs was accompanied by a substantial decrease in splenomegaly, T FH cells, GC B cells, PCs and autoantibodies (Fig. 8c,d and Supplementary Fig. 8d-f) . The reduction in the titers of antibodies to dsDNA reflected mainly a decrease in IgG2c antibodies rather than IgG1 antibodies (Fig. 8d) . The production of autoantibodies to single-stranded DNA (ssDNA), cardiolipin and nRNP was also substantially affected by the loss of Irf5 (Fig. 8e ). Furthermore, diminished expression of Irf5 ameliorated several parameters of renal injury in DKO mice, including expansion of the mesangial matrix, the presence of hyaline deposits, a decrease in capillary loops and the deposition of immunocomplexes ( Fig. 8f,g) . Thus, the aberrant population expansion of DKO ABCs in vivo was dependent on IRF5. Furthermore, decreasing the expression of Irf5 corrected several of the abnormalities observed in female DKO mice and considerably ameliorated the spontaneous development of lupus in these mice.
Discussion
The molecular networks that control ABCs in autoimmunity have remained largely unknown. Here we demonstrated that the SWEF proteins limited the generation of ABCs in response to IL-21. These cells exhibited a unique transcriptional profile and chromatin landscape enriched not only for T-bet binding sites but also for IRF and AP-1-BATF motifs. At a mechanistic level, the SWEF proteins inhibited the IL-21-driven formation of ABCs by controlling the accessibility of IRF5 to key targets. These studies thus elucidate a previously unknown pathway for the regulation of ABCs in autoimmunity.
The lack of SWEF proteins results in abnormalities in several key processes, including cell proliferation. This could promote both the premature accumulation of DKO ABCs and their dysregulated differentiation due to the close coupling of cell division and the acquisition of B cell transcriptional and epigenetic programs 40 . The expansion of DKO ABC populations could subsequently fuel autoimmunity via their dual ability to secrete proinflammatory mediators and produce autoantibodies. The deletion of Irf5 in DKO mice, however, could have affected other subsets, such as GC B cells and PCs, that produce autoantibodies and are dysregulated in DKO mice 32 . Thus, it remains to be established whether DKO ABCs contribute directly to autoimmunity or whether their accumulation is secondary to the chronic inflammation of autoimmune conditions. The distinctive features of ABCs from autoimmunity-prone mice were highlighted by their unique chromatin landscape, which exhibited enrichment for binding sites for IRFs and AP-1-BATF, in addition to the expected presence of motifs for T-bet. Those results were further supported by studies linking IRF5 to the regulation of ABCs. Given the known interplay between AP-1 and IRFs 14 , AP-1 proteins are also probably involved in the regulation of ABCs. IRF5-AP-1 crosstalk could be further facilitated by a potential feed-forward loop set-up by the IRF5-mediated induction of Jun. Notably, absence of the SWEF proteins resulted in increased binding of T-bet to several ABC-specific peaks, which occurred in an IRF5-dependent manner; this would suggest cooperativity between IRF5 and T-bet for at least some regulatory regions. That was reinforced by the requirement for the DNA-binding domain of IRF5 in the optimal recruitment of T-bet to ABC-specific sites. It remains to be determined whether IRF5 can function as a focused 'pioneer factor' for ABCs, as has been shown for IRF1 in T regulatory type 1 cells 41 .
The enrichment for IRF motifs in DKO ABC peaks was mechanistically linked to increased IRF5 activity due to lack of the inhibitory effects of the SWEF proteins. Both DEF6 and SWAP-70 are found in the nucleus 32, 42 , which suggests that they inhibit the activity of nuclear IRF5, a finding supported by our biochemical studies. Given their ability to bind to the IRF-association domain of IRF5, they could also potentially interfere with its crosstalk with AP-1 proteins 14 . Published studies showing that SWAP-70 can be recruited to some but not all IL-4-inducible promoters 42 furthermore suggest that the SWEF proteins could be recruited to distinct regulatory regions, depending on the precise composition and/or modifications of SWEF protein-containing complexes. This might enable the inhibitory actions of SWEF proteins to target specifically either IRF4 or IRF5. The inhibitory effects of SWEF proteins might also depend on the relative abundance of IRF5 and IRF4, which could vary depending on the ABC differentiation stage. Indeed, the IRF motifs within ABC-specific peaks could accommodate the binding of other IRFs such as IRF4, which could mark a more terminally differentiated ABC not captured by our analysis here. Furthermore, given the role of IRF4 in GC B cells 43 , we cannot exclude the possibility that IRF4 might be necessary at the earliest stages of ABC generation, which might not have been affected by deletion of Irf4 in CD11c-expressing DKO cells 37 . Given the complex array of biological responses controlled by DEF6 and SWAP-70, these two SWEF proteins might also restrain ABCs in vivo by acting separately on additional IRF-independent pathways.
ABCs from autoimmunity-prone mice also exhibited a substantial loss of accessible chromatin regions containing PU.1, MAF and C/EBP motifs, relative to the abundance of such regions in wild-type ABCs. Those changes were associated with downregulation of Maf and Mafb but not of Spi1, a pattern reminiscent of that employed by IFN-γ to disassemble enhancers that regulate M2-like macrophage programs 44 . This mechanism might be directly responsible for the decreased expression, in DKO ABCs, of Mertk and other genes encoding myeloid-related molecules involved in the engulfment of apoptotic cells, a pathway highly relevant to the pathogenesis of lupus. Given the known repressive role of PU.1 in antibody production and PC differentiation 45, 46 , selective depletion of PU.1bound peaks might also lessen the PU.1-mediated inhibitory effects that directly contribute to the increased transcription of immunoglobulin-encoding genes in DKO ABCs and endow them with an enhanced ability to undergo PC differentiation after exposure to environmental stimuli. Thus, dysregulated IRF5 activity, coupled with the loss of PU.1-containing repressive complexes, might represent a key mechanism employed by ABCs from autoimmunityprone mice to bypass critical checkpoints that govern the transition of B cells into antibody-secreting cells.
While the role for IRF5 in TLR7 signaling is well known 16 , our studies now indicate involvement of IRF5 downstream of IL-21 and thus position IRF5 as a common mediator of two key pathways for the generation of ABCs in autoimmunity. The convergence of these pathways onto IRF5 probably contributes to the dramatic effects of monoallelic deletion of Irf5 on the development of lupus in our model and other models 18, 20 . Such strong gene-dosage effects might be particular relevant for human SLE, in which IRF5 risk variants can affect IRF5 expression 15, 16 .Associations between SLE and variants of IL21, IL21R, DEF6 and IRF5 have all been identified in genome-wide association studies, which raises the intriguing possibility that improper regulation of this pathway has a key role in the pathogenesis of SLE. Several polymorphisms in DEF6, which is located centromeric to the locus encoding the major histocompatibility complex 26 , have been reported, and population expansion of ABC-like cells and aberrancies in IL21-IL21R or IRF5 have also been observed in other autoimmune conditions such as rheumatoid arthritis and inflammatory bowel disease 4, [47] [48] [49] [50] . Dysregulation of the ability of the SWEF proteins to restrain IRF5's activity in response to IL-21 and to properly control ABCs might thus contribute to multiple autoimmune diseases.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41590-018-0056-8.
or IgG2c (1079-05) (SouthernBiotech). Anti-ssDNA and anti-nRNP IgG ELISAs were obtained from Alpha Diagnostic International. OD 450 was measured on a microplate reader. ANAs were detected on Hep-2 slides (MBL international) at a 1:200 dilution using Alexa Flour 488-conjugated anti-mouse IgG (715-546-151, Jackson ImmunoResearch Laboratories). Fluorescent intensity was semiquantitated as previously described 52 .
Histology and immunofluorescence staining. Tissue specimens were fixed in 10% neutral buffered formalin and embedded in paraffin. Tissue sections were stained with periodic acid-Schiff and were analyzed by light microscopy. The nephritis scoring system was adapted from the International Society of Nephrology-Renal Pathology Society classification of human lupus nephritis. At least 40 glomeruli per mouse were evaluated. The final score accounted for morphological pattern (mesangial, capillary and/or membranous) and for the proportion of glomeruli involved. Immunofluorescence analysis of frozen kidney sections was performed by staining with FITC-labeled goat anti-mouse IgG (715-096-151, Jackson ImmunoResearch Laboratories) and specimens were analyzed with a LSM 510 laser scanning confocal microscope (Carl Zeiss, Inc.). Images were captured by Q capture software. Five representative glomeruli per mouse were chosen and mean fluorescence intensity (MFI) was calculated using ImageJ software.
RNA-Seq analysis. Total RNA was isolated using RNeasy Plus Mini kit (Qiagen). A SMART-Seq v3 Ultra Low Input RNA Kit (Clontech) followed by preparation of a Nextera library were used to prepare Illumina-compatible sequencing libraries. Quality of all RNA and library preparations were evaluated with BioAnalyser 2100 (Agilent). Sequencing libraries were pair-end sequenced by the Weill Cornell Epigenomics Core using HiSeq2500 at the depth of ~30-50 million fragments per sample. Sequencing performance was evaluated using FASTQC. 50-bp paired reads were mapped to mouse genome (mm10, build 38.75, 41,128 genes and 87,108 transcripts) with CLC Bio Genomic Workbench 7.5 software (Qiagen). Duplicated reads with more than five copies were discarded. Read count tables were created using unique exon read counts and the differential expression was analyzed using EDGER (Bioconductor). Genes with the expression less than 1 count per million (cpm) in at least three conditions were considered non-expressing and were removed from further analysis. A negative binomial generalized log-linear model was fit to read counts for each gene. A likelihood ratio tests with the null hypothesis that the pairwise contrasts of the coefficients are equal to zero was used to evaluate the significance of differences in expression between analyzed groups. The Benjamini-Hochberg false-discovery rate (FDR) procedure was used to correct for multiple testing. Genes with a FDR-corrected P value of > 0.01 and a change in expression of less than twofold were filtered out. Genes that passed the filtering were considered to be differentially expressed.
Gene Set Enrichment Analysis (GSEA; http://www.broad.mit.edu/gsea/index. html) was performed using the difference of log-transformed count per million (cpm) for contrasted conditions as a ranking metric. The Molecular Signatures DataBase v 5.2 (Broad Institute) was used as source of gene sets with defined functional relevance. Gene sets ranging between 15 genes and 1000 genes were included into analysis. Nominal P values were FDR corrected, and gene sets with an FDR of < 0.05 were used to create GSEA enrichment plot. To define the groups of potentially co-regulated genes, we performed unsupervised hierarchical clustering analysis of log-transformed expression values (cpm) in R. The distances between genes were calculated as (1 -Pearson correlation). The Euclidean distance was used to determine the distances between samples. Ward.D2 methods was used to perform clustering. The expression values were z-transformed and visualized using heat maps. ATAC-seq, peak calling and annotation. The nuclei of sorted wild-type and DKO ABCs or DKO FoB cells were prepared by incubation of cells with nuclear preparation buffer (0.30 M sucrose, 10 mM Tris, pH 7.5, 60 mM KCl, 15 mM NaCl, 5 mM MgCl 2 , 0.1 mM EGTA, 0.1% NP40, 0.15 mM spermine, 0.5 mM spermidine and 2 mM 6AA) 53 . Libraries were prepared as described previously 35 . Paired-end 50-bp sequences were generated from samples on an Illumina HiSeq2500. We used the makeTagDirectory followed by findPeaks command from HOMER version 4.7.2 (http://homer.salk.edu/homer/) to identify peaks of ATAC-seq. A falsediscovery rate (FDR) threshold of 0.001 was used for all data sets. The following HOMER command was used: cmd = findPeaks < sample tag directory> -style factor or histone -o < output file> -i < input tag directory> . The total number of mapped reads in each sample was normalized to ten million mapped reads. Peakassociated genes were defined based on the closest genes to these genomic regions using RefSeq coordinates of genes. We used the annotatePeaks command from HOMER to calculate ATAC-seq tag densities from different experiments and to create heatmaps of tag densities. Sequencing data were visualized by preparing custom tracks for the UCSC Genome browser.
Motif enrichment analysis. De novo transcription factor motif analysis was performed with motif finder program findMotifsGenome from HOMER package, on given ATAC-seq peaks. Peak sequences were compared to random genomic fragments of the same size and normalized G + C content to identify motifs enriched in the targeted sequences.
Statistics. P values were calculated with unpaired two-tailed Student's t-test
for two-group comparisons and by one-way ANOVA followed by Bonferroni's multiple-comparisons test for multi-group comparisons. For statistical analysis of ANA intensity scores, a non-parametric Mann-Whitney test was used. P values of < 0.05 were considered significant; and the following values were delineated: *P < 0.05, **P < 0.01, ***P < 0.001 and ***P < 0.0001. Statistical analysis was performed with Graphpad Prism 7.
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Experimental design 1. Sample size
Describe how sample size was determined.
The sample size was chosen based on the literature in the field. For in vivo B cells activation, previous studies by Fanzo et al. and Jordan provided the model for observing lymphocyte activation and differentiation. Their results found that approximately 60% of female mice developed lupus-like syndrome in aging Def6-deficient mice compared to none in the comparison group (p<0.005). Using those estimates, it was shown that sample sizes of five (5) achieve 95% power to detect a 60% incidence difference between the comparison groups with a significance level set at 0.05.
Data exclusions
Describe any data exclusions.
Outliers were identified by the ROUT method (GRAPHPAD) and removed from analysis. In RNA-seq experiments, genes with the expression levels less than 1 count per million (cpm) in at least three conditions were considered non-expressing and removed from further analysis.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
Each experimental findings were reproducibles. Experimental findings were reproduced at least twice. Most of the findings were reproduced by different laboratory members at different times.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
No Randomization was used.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Blinding was used during the ANA evaluation. Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed). n/a Confirmed The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons Test values indicating whether an effect is present Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Statistics were calculated using Graphpad Prism 7. Softwares used for RNAseq and ATAC-seq analysis are described in the method section. FACS data were collected using FACS DIVA and analyzed using FlowJo v9.9.6. ImageJ 1.48u4 was used for immunoblots and IgG deposition quantification.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party.
Unique materials are available upon request.
Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species). Policy information about studies involving human research participants
nature research | life sciences reporting summary
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
The study did not involve human participants
